Cargando…

Platelet-to-lymphocyte ratio and the first occurrence of peritonitis in peritoneal dialysis patients

BACKGROUND: Platelet-to-lymphocyte ratio (PLR) has been used as a potential biomarker of inflammation-related diseases, but its role in the peritoneal dialysis-related peritonitis (PDRP) is still uncertain. This study was aimed to investigate the association between PLR and the new-onset PDRP in per...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Ning, Zheng, Yijia, Zhang, Xing, Tang, Xingming, Tang, Li-wen, Wang, Qinqin, Chen, Xingyu, Wang, Xiaoyang, Wen, Yueqiang, Feng, Xiaoran, Zhou, Qian, Zhou, Jiafan, Li, Yafang, Shang, Sijia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803258/
https://www.ncbi.nlm.nih.gov/pubmed/36585653
http://dx.doi.org/10.1186/s12882-022-03038-5
_version_ 1784861843290849280
author Su, Ning
Zheng, Yijia
Zhang, Xing
Tang, Xingming
Tang, Li-wen
Wang, Qinqin
Chen, Xingyu
Wang, Xiaoyang
Wen, Yueqiang
Feng, Xiaoran
Zhou, Qian
Zhou, Jiafan
Li, Yafang
Shang, Sijia
author_facet Su, Ning
Zheng, Yijia
Zhang, Xing
Tang, Xingming
Tang, Li-wen
Wang, Qinqin
Chen, Xingyu
Wang, Xiaoyang
Wen, Yueqiang
Feng, Xiaoran
Zhou, Qian
Zhou, Jiafan
Li, Yafang
Shang, Sijia
author_sort Su, Ning
collection PubMed
description BACKGROUND: Platelet-to-lymphocyte ratio (PLR) has been used as a potential biomarker of inflammation-related diseases, but its role in the peritoneal dialysis-related peritonitis (PDRP) is still uncertain. This study was aimed to investigate the association between PLR and the new-onset PDRP in peritoneal dialysis (PD) patients. METHODS: In this multicenter retrospective study, 1378 PD Chinese PD patients were recruited from four centers, who were divided into the high PLR group (HPG) and the low PLR group (LPG) according to the cutoff value of PLR. The correlation between PLR and the new-onset PDRP was assessed using the Cox regression model analysis. RESULTS: During follow-up, 121 new-onset PDRP events were recorded. Kaplan–Meier survival curve showed a higher risk of new-onset PDRP in the HPG (log-rank test, P < 0.001). After adjusting for confounding factors, the Cox regression model showed the risk of new-onset PDRP was higher in the HPG than that in the LPG (HR 1.689, 95%CI 1.096–2.602, P = 0.017). Competitive risk model analysis showed that significant differences still existed between the two PLR groups in the presence of other competitive events (P < 0.001). CONCLUSION: PLR is independently associated with the new-onset PDRP in PD patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-022-03038-5.
format Online
Article
Text
id pubmed-9803258
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98032582023-01-01 Platelet-to-lymphocyte ratio and the first occurrence of peritonitis in peritoneal dialysis patients Su, Ning Zheng, Yijia Zhang, Xing Tang, Xingming Tang, Li-wen Wang, Qinqin Chen, Xingyu Wang, Xiaoyang Wen, Yueqiang Feng, Xiaoran Zhou, Qian Zhou, Jiafan Li, Yafang Shang, Sijia BMC Nephrol Research BACKGROUND: Platelet-to-lymphocyte ratio (PLR) has been used as a potential biomarker of inflammation-related diseases, but its role in the peritoneal dialysis-related peritonitis (PDRP) is still uncertain. This study was aimed to investigate the association between PLR and the new-onset PDRP in peritoneal dialysis (PD) patients. METHODS: In this multicenter retrospective study, 1378 PD Chinese PD patients were recruited from four centers, who were divided into the high PLR group (HPG) and the low PLR group (LPG) according to the cutoff value of PLR. The correlation between PLR and the new-onset PDRP was assessed using the Cox regression model analysis. RESULTS: During follow-up, 121 new-onset PDRP events were recorded. Kaplan–Meier survival curve showed a higher risk of new-onset PDRP in the HPG (log-rank test, P < 0.001). After adjusting for confounding factors, the Cox regression model showed the risk of new-onset PDRP was higher in the HPG than that in the LPG (HR 1.689, 95%CI 1.096–2.602, P = 0.017). Competitive risk model analysis showed that significant differences still existed between the two PLR groups in the presence of other competitive events (P < 0.001). CONCLUSION: PLR is independently associated with the new-onset PDRP in PD patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-022-03038-5. BioMed Central 2022-12-30 /pmc/articles/PMC9803258/ /pubmed/36585653 http://dx.doi.org/10.1186/s12882-022-03038-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Su, Ning
Zheng, Yijia
Zhang, Xing
Tang, Xingming
Tang, Li-wen
Wang, Qinqin
Chen, Xingyu
Wang, Xiaoyang
Wen, Yueqiang
Feng, Xiaoran
Zhou, Qian
Zhou, Jiafan
Li, Yafang
Shang, Sijia
Platelet-to-lymphocyte ratio and the first occurrence of peritonitis in peritoneal dialysis patients
title Platelet-to-lymphocyte ratio and the first occurrence of peritonitis in peritoneal dialysis patients
title_full Platelet-to-lymphocyte ratio and the first occurrence of peritonitis in peritoneal dialysis patients
title_fullStr Platelet-to-lymphocyte ratio and the first occurrence of peritonitis in peritoneal dialysis patients
title_full_unstemmed Platelet-to-lymphocyte ratio and the first occurrence of peritonitis in peritoneal dialysis patients
title_short Platelet-to-lymphocyte ratio and the first occurrence of peritonitis in peritoneal dialysis patients
title_sort platelet-to-lymphocyte ratio and the first occurrence of peritonitis in peritoneal dialysis patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803258/
https://www.ncbi.nlm.nih.gov/pubmed/36585653
http://dx.doi.org/10.1186/s12882-022-03038-5
work_keys_str_mv AT suning platelettolymphocyteratioandthefirstoccurrenceofperitonitisinperitonealdialysispatients
AT zhengyijia platelettolymphocyteratioandthefirstoccurrenceofperitonitisinperitonealdialysispatients
AT zhangxing platelettolymphocyteratioandthefirstoccurrenceofperitonitisinperitonealdialysispatients
AT tangxingming platelettolymphocyteratioandthefirstoccurrenceofperitonitisinperitonealdialysispatients
AT tangliwen platelettolymphocyteratioandthefirstoccurrenceofperitonitisinperitonealdialysispatients
AT wangqinqin platelettolymphocyteratioandthefirstoccurrenceofperitonitisinperitonealdialysispatients
AT chenxingyu platelettolymphocyteratioandthefirstoccurrenceofperitonitisinperitonealdialysispatients
AT wangxiaoyang platelettolymphocyteratioandthefirstoccurrenceofperitonitisinperitonealdialysispatients
AT wenyueqiang platelettolymphocyteratioandthefirstoccurrenceofperitonitisinperitonealdialysispatients
AT fengxiaoran platelettolymphocyteratioandthefirstoccurrenceofperitonitisinperitonealdialysispatients
AT zhouqian platelettolymphocyteratioandthefirstoccurrenceofperitonitisinperitonealdialysispatients
AT zhoujiafan platelettolymphocyteratioandthefirstoccurrenceofperitonitisinperitonealdialysispatients
AT liyafang platelettolymphocyteratioandthefirstoccurrenceofperitonitisinperitonealdialysispatients
AT shangsijia platelettolymphocyteratioandthefirstoccurrenceofperitonitisinperitonealdialysispatients